14.8 C
Washington

Eli Lilly could launch obesity drug in India next year | Reuters News Agency

Date:

Share:

Health

Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review. 

Market Impact

The market opportunity is huge in the world’s most populous country, which has high obesity rates, especially among women, and the second-highest number of people with type-2 diabetes globally.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Asia

Countries: India

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

Subscribe to our magazine

━ more like this

S&P 500 futures are little changed ahead of May jobs report: Live updates

Traders work on the floor at the New York Stock Exchange (NYSE), on the day of Circle Internet Group's IPO, in New York City,...

Labubu Mania: How BLACKPINK'S Lisa Made This Oddball Toy A Viral Must-Have | Know EVERYTHING | N18G

Last Updated:June 05, 2025, 23:00 IST LifestyleLabubu, the mischievous yet kind-hearted vinyl toy from Pop Mart’s ‘The Monsters’ series, has taken the internet...

Major data broker hack impacts 364,000 individuals’ data

NEWYou can now listen to Fox News articles! Americans’ personal data is now spread across more digital platforms than ever. From online...

Why Plant-Based Protein Fits Better With Your Skin And Gut Goals?

In today’s world of mindful eating and holistic wellness, it’s not enough for your nutrition to only build muscle or aid weight loss, it...